BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31342363)

  • 1. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.
    Mamtani A; Zabor EC; Stempel M; Morrow M
    Ann Surg Oncol; 2019 Oct; 26(10):3269-3274. PubMed ID: 31342363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.
    Morrow M; Van Zee KJ; Patil S; Petruolo O; Mamtani A; Barrio AV; Capko D; El-Tamer M; Gemignani ML; Heerdt AS; Kirstein L; Pilewskie M; Plitas G; Sacchini VS; Sclafani LM; Ho A; Cody HS
    Ann Surg; 2017 Sep; 266(3):457-462. PubMed ID: 28650355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
    Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
    Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis.
    Gao W; Zeng Y; Fei X; Chen X; Shen K
    Breast Cancer Res Treat; 2020 Nov; 184(1):193-202. PubMed ID: 32740809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
    Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
    Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Importance of Applying ACOSOG Z0011 Criteria in the Axillary Management of Invasive Lobular Carcinoma: A Multi-institutional Cohort Study.
    Roberts A; Nofech-Mozes S; Youngson B; McCready DR; Al-Assi M; Ramkumar S; Cil T
    Ann Surg Oncol; 2015 Oct; 22(10):3397-401. PubMed ID: 26215196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy.
    Dengel LT; Van Zee KJ; King TA; Stempel M; Cody HS; El-Tamer M; Gemignani ML; Sclafani LM; Sacchini VS; Heerdt AS; Plitas G; Junqueira M; Capko D; Patil S; Morrow M
    Ann Surg Oncol; 2014 Jan; 21(1):22-7. PubMed ID: 23975314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
    Barrio AV; Downs-Canner S; Edelweiss M; Van Zee KJ; Cody HS; Gemignani ML; Pilewskie ML; Plitas G; El-Tamer M; Kirstein L; Capko D; Patil S; Morrow M
    Ann Surg Oncol; 2020 May; 27(5):1617-1624. PubMed ID: 31820212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Lobbezoo DJ; Tjan-Heijnen VC; Voogd AC
    Clin Breast Cancer; 2016 Aug; 16(4):e75-82. PubMed ID: 27116948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
    Cipolla C; Lupo S; Grassi N; Tutino G; Greco M; Eleonora D; Gebbia V; Valerio MR
    World J Surg Oncol; 2024 Apr; 22(1):100. PubMed ID: 38627759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed?
    Subhedar P; Stempel M; Eaton A; Morrow M; Gemignani ML
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S470-5. PubMed ID: 26178759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers.
    Corona SP; Bortul M; Scomersi S; Bigal C; Bottin C; Zanconati F; Fox SB; Giudici F; Generali D
    Breast Cancer Res Treat; 2020 Apr; 180(3):735-745. PubMed ID: 32060782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery.
    Chung A; Gangi A; Mirocha J; Giuliano A
    Ann Surg Oncol; 2015 Apr; 22(4):1128-32. PubMed ID: 25300606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer.
    Gooch J; King TA; Eaton A; Dengel L; Stempel M; Corben AD; Morrow M
    Ann Surg Oncol; 2014 Sep; 21(9):2897-903. PubMed ID: 24777858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma.
    Horvath JW; Barnett GE; Jimenez RE; Young DC; Povoski SP
    World J Surg Oncol; 2009 Mar; 7():34. PubMed ID: 19317888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.
    Taras AR; Hendrickson NA; Pugliese MS; Lowe KA; Atwood M; Beatty JD
    Am J Surg; 2009 May; 197(5):643-6; discussion 646-7. PubMed ID: 19393357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.